144 related articles for article (PubMed ID: 25219695)
1. [Mania with psychotic feature induced by the use of pramipexole in Parkinson's disease: a case report].
Meriç C; Pirdoğan E; Günday Toker Ö; Tekin A; Bakım B; Çelik S
Turk Psikiyatri Derg; 2014; 25(3):212-4. PubMed ID: 25219695
[TBL] [Abstract][Full Text] [Related]
2. Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial.
Barone P; Poewe W; Albrecht S; Debieuvre C; Massey D; Rascol O; Tolosa E; Weintraub D
Lancet Neurol; 2010 Jun; 9(6):573-80. PubMed ID: 20452823
[TBL] [Abstract][Full Text] [Related]
3. Pramipexole in psychiatry: a systematic review of the literature.
Aiken CB
J Clin Psychiatry; 2007 Aug; 68(8):1230-6. PubMed ID: 17854248
[TBL] [Abstract][Full Text] [Related]
4. Pramipexole, ropinirole, and mania in Parkinson's disease.
Singh A; Althoff R; Martineau RJ; Jacobson J
Am J Psychiatry; 2005 Apr; 162(4):814-5. PubMed ID: 15800169
[No Abstract] [Full Text] [Related]
5. Pramipexole-induced obsessive-compulsive symptoms in a patient with Parkinson's disease and disgust sensitivity.
Gopalan P; Azzam PN; Hudak R
Psychosomatics; 2013; 54(3):286-9. PubMed ID: 23218062
[No Abstract] [Full Text] [Related]
6. [Severe leg edema associated with the use of dopaminergic drugs in Parkinson's disease. Report of one case].
Miranda C M; Hudson A L
Rev Med Chil; 2017 Dec; 145(12):1624-1625. PubMed ID: 29652961
[TBL] [Abstract][Full Text] [Related]
7. Exercise dependence induced by pramipexole in Parkinson's Disease-a case report.
Vitale C; Santangelo G; Verde F; Amboni M; Sorrentino G; Grossi D; Barone P
Mov Disord; 2010 Dec; 25(16):2893-4. PubMed ID: 20687190
[No Abstract] [Full Text] [Related]
8. Reversible antecollis associated with pramipexole in a patient with Parkinson's disease.
Kim HJ; Jeon BS; Kim SH; Han SH
J Clin Neurosci; 2012 Jun; 19(6):903-4. PubMed ID: 22353251
[TBL] [Abstract][Full Text] [Related]
9. Pramipexole extended-release (once-daily formulation) for the treatment of Parkinson's disease.
Perez Lloret S; Rascol O
Expert Opin Pharmacother; 2010 Sep; 11(13):2221-30. PubMed ID: 20670197
[TBL] [Abstract][Full Text] [Related]
10. Long-term retention rate of pramipexole in the treatment of Parkinson's disease.
Keränen T; Tuhkasaari M; Kuusisto H
Eur J Clin Pharmacol; 2009 Sep; 65(9):955-6; author reply 957. PubMed ID: 19415250
[No Abstract] [Full Text] [Related]
11. Panic attack-like episodes possibly induced by pramipexole in a patient with young-onset Parkinson's disease.
de Cerqueira AC; Nardi AE
J Neuropsychiatry Clin Neurosci; 2011; 23(3):E21. PubMed ID: 21948911
[No Abstract] [Full Text] [Related]
12. Auditory musical hallucinations associated with extended-release pramipexole in an elderly patient with Parkinson's disease.
Kataoka H; Ueno S
Medicine (Baltimore); 2014 Dec; 93(27):e251. PubMed ID: 25501095
[TBL] [Abstract][Full Text] [Related]
13. Telogen effluvium associated with the dopamine agonist pramipexole in a 55-year-old woman with Parkinson's disease.
Katz KA; Cotsarelis G; Gupta R; Seykora JT
J Am Acad Dermatol; 2006 Nov; 55(5 Suppl):S103-4. PubMed ID: 17052518
[No Abstract] [Full Text] [Related]
14. Pramipexole-induced limb dystonia and its associated complex regional pain syndrome in idiopathic Parkinson's disease: A case report.
Park D
Medicine (Baltimore); 2017 Jul; 96(28):e7530. PubMed ID: 28700507
[TBL] [Abstract][Full Text] [Related]
15. Pramipexole extended release: in Parkinson's disease.
Chwieduk CM; Curran MP
CNS Drugs; 2010 Apr; 24(4):327-36. PubMed ID: 20297857
[TBL] [Abstract][Full Text] [Related]
16. Long-term effect of initiating pramipexole vs levodopa in early Parkinson disease.
Parkinson Study Group CALM Cohort Investigators
Arch Neurol; 2009 May; 66(5):563-70. PubMed ID: 19433655
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of a once-daily extended-release formulation of pramipexole switched from an immediate-release formulation in patients with advanced Parkinson's disease: results from an open-label study.
Takanashi M; Shimo Y; Hatano T; Oyama G; Hattori N
Drug Res (Stuttg); 2013 Dec; 63(12):639-43. PubMed ID: 23884661
[TBL] [Abstract][Full Text] [Related]
18. Impact of pramipexole on the onset of levodopa-related dyskinesias.
Constantinescu R; Romer M; McDermott MP; Kamp C; Kieburtz K;
Mov Disord; 2007 Jul; 22(9):1317-9. PubMed ID: 17534955
[TBL] [Abstract][Full Text] [Related]
19. [Stealing as an Impulse Control Disorder Associated with Pramipexole - A Case Report from Forensic Psychiatric Practice].
Clemm von Hohenberg C; Dreßing H
Psychiatr Prax; 2017 Apr; 44(3):172-174. PubMed ID: 28399600
[TBL] [Abstract][Full Text] [Related]
20. Pramipexole. A review of its use in the management of early and advanced Parkinson's disease.
Dooley M; Markham A
Drugs Aging; 1998 Jun; 12(6):495-514. PubMed ID: 9638397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
